OverviewSuggest Edit

Ra Medical Systems is a company that develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological diseases. It offers DABRA (destruction of arteriosclerotic blockages by laser radiation ablation), a minimally-invasive excimer laser and disposable catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. The company also provides Pharos, an excimer laser device that emits concentrated ultraviolet light used in the treatment of dermatological skin disorders.

TypePublic
Founded2002
HQCarlsbad, CA, US
Websiteramed.com

Latest Updates

Employees (est.) (Sept 2021)67(-22%)
Revenue (FY, 2020)$4.4 M(-38%)
Share Price (May 2022)$0.3(-12%)
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Ra Medical Systems

Martin Colombatto

Martin Colombatto

Chairman of the Board
Will McGuire

Will McGuire

Chief Executive Officer and Director
Andrew Jackson

Andrew Jackson

Chief Financial Officer
Chris Folk

Chris Folk

Vice President, Engineering
Maria Villanueva

Maria Villanueva

Vice President and Compliance Officer
Al Memmolo

Al Memmolo

Vice President, Clinical, Quality and Regulatory Affairs
Show more

Ra Medical Systems Office Locations

Ra Medical Systems has an office in Carlsbad
Carlsbad, CA, US (HQ)
2070 Las Palmas Dr
Show all (1)

Ra Medical Systems Financials and Metrics

Ra Medical Systems Revenue

Embed Graph
View revenue for all periods
Ra Medical Systems's revenue was reported to be $4.41 m in FY, 2020 which is a 38.8% decrease from the previous period.
USD

Revenue (Q3, 2021)

5.0k

Gross profit (Q3, 2021)

(241.0k)

Gross profit margin (Q3, 2021), %

(4820%)

Net income (Q3, 2021)

(4.3m)

EBIT (Q3, 2021)

(7.4m)

Market capitalization (11-May-2022)

1.9m

Closing stock price (11-May-2022)

0.3

Cash (30-Sept-2021)

20.6m

EV

(16.3m)
Ra Medical Systems's current market capitalization is $1.9 m.
Annual
USDFY, 2018FY, 2019FY, 2020

Revenue

6.3m7.2m4.4m

Revenue growth, %

7%15%(39%)

Cost of goods sold

4.2m8.9m5.5m

Gross profit

2.1m(1.7m)(1.1m)
Quarterly
USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021

Revenue

1.7m2.2m1.9m1.4m900.0k914.0k1.1m1.0m5.0k

Cost of goods sold

1.9m2.7m2.4m1.6m1.2m1.4m1.4m1.5m246.0k

Gross profit

(194.0k)(580.0k)(517.0k)(210.0k)(267.0k)(504.0k)(255.0k)(483.0k)(241.0k)

Gross profit Margin, %

(11%)(27%)(27%)(15%)(30%)(55%)(23%)(48%)(4820%)
Annual
USDFY, 2018FY, 2019FY, 2020

Cash

64.3m14.6m23.9m

Accounts Receivable

1.3m786.0k238.0k

Prepaid Expenses

1.5m1.9m1.3m

Inventories

2.1m2.8m2.2m
Quarterly
USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021

Cash

55.1m11.8m14.5m18.4m29.4m33.6m16.0m20.2m20.6m

Accounts Receivable

1.3m1.5m1.3m684.0k474.0k475.0k160.0k228.0k17.0k

Prepaid Expenses

1.8m1.3m1.1m1.8m1.2m466.0k1.6m1.3m1.2m

Inventories

2.2m2.3m2.6m2.8m2.7m2.6m2.2m2.3m997.0k
Annual
USDFY, 2018FY, 2019FY, 2020

Net Income

(30.8m)(57.0m)(36.0m)

Depreciation and Amortization

624.0k1.4m4.4m

Inventories

(3.9m)(2.2m)352.0k

Accounts Payable

699.0k407.0k(961.0k)
USDFY, 2018

Revenue/Employee

65.2k

Financial Leverage

1.1 x
Show all financial metrics

Ra Medical Systems Operating Metrics

FY, 2018FY, 2019FY, 2020Nov, 2021

Facility Space, sq. ft.

32 k32 k32 k

Patents (US)

4669

Patent Applications (US)

8

Trademarks (US)

4
Show all operating metrics

Ra Medical Systems Revenue Breakdown

Embed Graph

Ra Medical Systems revenue breakdown by business segment: 5.9% from Vascular and 94.1% from Dermatology

Ra Medical Systems revenue breakdown by geographic segment: 5.1% from All other countries and 94.9% from United States

Ra Medical Systems Cybersecurity Score

Cybersecurity ratingPremium dataset

A

95/100

SecurityScorecard logo

Ra Medical Systems Online and Social Media Presence

Embed Graph

Ra Medical Systems News and Updates

STRATA Skin Sciences Announces Acquisition of the U.S. Dermatology Business of Ra Medical Systems

HORSHAM, Pa., Aug. 16, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced the acquisition of the U.S. dermatology …

WeissLaw LLP: Ra Medical Systems, Inc. is the Subject of a Legal Investigation

NEW YORK, Oct. 4, 2019 /PRNewswire/ -- WeissLaw LLP, a national class action and shareholders' rights law firm with offices in New York, Los Angeles and Atlanta, announces an investigation of Ra Medical Systems, Inc. (NYSE: RMED) ("RMED," or the "Company"). If you own RMED shares and wish...

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Ra Medical Systems, Inc. To Contact The Firm

NEW YORK, July 12, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Ra Medical Systems, Inc. (Ra Medical or the "Company") (NYSE:RMED) of the August 6, 2019 deadline to seek the role of lead plaintiff in a federal securities class...

RM LAW Announces Class Action Lawsuit Against Ra Medical Systems, Inc.

BERWYN, Pa., June 26, 2019 /PRNewswire/ -- RM LAW, P.C. announces that a class action lawsuit has been filed on behalf of all persons or entities that purchased Ra Medical Systems, Inc. ("Ra Medical" or the "Company") (NYSE: RMED) common stock pursuant and/or traceable to the Company's...

RA MEDICAL INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Ra Medical Systems, Inc. To Contact The Firm

NEW YORK, June 7, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ra Medical Systems, Inc. ("Ra Medical" or the "Company") (NYSE:RMED). If you invested in Ra Medical stock or options and would like to discuss...

Former California Deputy Attorney General and Special Counsel with Johnson Fistel Launches Investigation into Ra Medical Systems, Inc. (RMED)

SAN DIEGO, June 5, 2019 /PRNewswire/ -- Shareholder Rights Law Firm Johnson Fistel, LLP with the assistance of former California Deputy Attorney General and Special Counsel, Tiffany Johnson, Esq., is investigating potential claims against Ra Medical Systems, Inc. ("Ra Medical") (NYSE:...

Ra Medical Systems Blogs

Ra Medical Systems to Report First Quarter 2022 Financial Results on May 16, 2022

CARLSBAD, Calif.--(BUSINESS WIRE)-- Ra Medical Systems, Inc. (NYSE American: RMED) announces that it will report financial results for the three months ended March 31, 2022 after market close on Monday, May 16. Ra Medical management will hold an investment community conference call that day at 1…

Ra Medical Systems Granted U.S. Patent for Laser Ablation Catheters with Expanded Ablation Area

CARLSBAD, Calif.--(BUSINESS WIRE)-- Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to treat vascular diseases, announces the United States Patent and Trademark Office has granted the company a patent for liquid-filled lase…

Ra Medical Systems Achieves Milestone of 100 Subjects Enrolled in its Pivotal Atherectomy Clinical Study

CARLSBAD, Calif.--(BUSINESS WIRE)-- Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to treat vascular diseases, announces the achievement of a milestone with the enrollment of 100 subjects in its pivotal clinical study to e…

Ra Medical Systems Reports 2021 Fourth Quarter and Full Year Financial Results

Conference call begins at 4:30 p.m. Eastern time today CARLSBAD, Calif.--(BUSINESS WIRE)-- Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to treat vascular disease, reports financial results for the three months and full…

Ra Medical Systems to Report 2021 Fourth Quarter and Full Year Financial Results on March 23, 2022

CARLSBAD, Calif.--(BUSINESS WIRE)-- Ra Medical Systems, Inc. (NYSE American: RMED) announces that it will report 2021 fourth quarter and full year financial results after market close on Wednesday, March 23. Ra Medical management will hold an investment community conference call that day at 1:30…

Ra Medical Systems Files 510(k) Application for the DABRA Catheter with Braided Overjacket and Six-Month Shelf Life

CARLSBAD, Calif.--(BUSINESS WIRE)-- Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to treat vascular diseases, announces the filing of a 510(k) application with the U.S. Food and Drug Administration (FDA) for the company’s…
Show more

Ra Medical Systems Frequently Asked Questions

  • When was Ra Medical Systems founded?

    Ra Medical Systems was founded in 2002.

  • Who are Ra Medical Systems key executives?

    Ra Medical Systems's key executives are Martin Colombatto, Will McGuire and Andrew Jackson.

  • How many employees does Ra Medical Systems have?

    Ra Medical Systems has 67 employees.

  • What is Ra Medical Systems revenue?

    Latest Ra Medical Systems annual revenue is $4.4 m.

  • What is Ra Medical Systems revenue per employee?

    Latest Ra Medical Systems revenue per employee is $65.7 k.

  • Who are Ra Medical Systems competitors?

    Competitors of Ra Medical Systems include STRATA Skin Sciences, National Biological and Becton Dickinson.

  • Where is Ra Medical Systems headquarters?

    Ra Medical Systems headquarters is located at 2070 Las Palmas Dr, Carlsbad.

  • Where are Ra Medical Systems offices?

    Ra Medical Systems has an office in Carlsbad.

  • How many offices does Ra Medical Systems have?

    Ra Medical Systems has 1 office.